| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
Departments of
*
Pathology and
Medicine, Brigham and Women’s Hospital, and
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The mechanism(s) whereby immature MCs leave the bloodstream during normal development, or in the context of inflammatory responses, remain poorly understood. It appears likely, based upon studies of other leukocytes, that the emigration of MC precursors into the tissue requires their interaction with the blood vessel wall, a process that in leukocytes is mediated by leukocyte adhesion receptors such as the ß2 integrins. The ß2 integrin Mac-1 (CD11b/CD18, CR3) is present on neutrophils, monocytes, NK cells, eosinophils, and basophils and has also been shown to be weakly expressed on a human leukemic MC line HMC-1 (9), and in a small fraction (<5%) of in vitro-derived human MCs (10). Although Mac-1 has not been detected in mature MCs isolated from various human tissues (11), it is possible that the techniques for isolation of such cells which require enzymatic digestion, may have altered surface Mac-1 expression. Alternatively, Mac-1 may not be expressed in the mature MCs of the tissues examined. Thus, the expression of Mac-1 on non-neoplastic, in vivo-derived tissue MCs, and its relevance to MC development and/or function, has not been previously reported. Mac-1 mediates many leukocyte functions including leukocyte adhesion to the endothelium (12). Mice deficient in this receptor have defects in several neutrophil functions (13, 14, 15). In this study, we show that Mac-1 is expressed on normal PMCs and that it is important both in establishing resident MC populations and in the expression of MC-dependent innate immunity.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Mice which lack Mac-1 (Mac-1-/-), generated by gene targeting (13), and their littermate wild-type controls were bred and maintained in a virus Ab-free facility at the Longwood Medical Research Center of the Harvard Medical School (Boston, MA). The Mac-1-/- and wild-type colonies are of a mixed C57Bl/129Sv background that is maintained by ongoing heterozygous breedings. Mice from these litters are then used to set up wild-type and homozygous matings. To prevent the two genotypes from straying in their background genes, new breedings with mice derived from heterozygous breedings are set up routinely, avoiding matings between littermates. Animals used for experiments were age- and sex-matched for each experiment described.
Isolation of PMCs
The peritoneum of mice was lavaged as previously described (16). For flow cytometric sorting, cells were stained with a phycoerythrin (PE)-conjugated mAb to CD117 (c-kit) (clone 2B8; PharMingen, San Diego, CA) and sorted on a flow cytometer (EPICS Elite; Coulter, Miami, FL). In select experiments, PMCs were purified using a 22.5% metrizamide gradient as previously described (17).
Isolation and culture of bone marrow-derived cultured MCs (BMCMCs)
BMCMCs were obtained by culturing bone marrow cells from 4- to 6-wk-old wild-type and Mac-1-/- mice in medium containing 100 U/ml of murine rIL-3 for 7–8 wk as previously described (18). BMCMC populations were >90% c-kit positive. In some experiments cells were incubated with LPS from Escherichia coli 0.26:B6 (Difco, Detroit, MI) for 24 h.
Immunofluorescence staining and flow cytometric analysis
c-kit-PE labeled PMCs, recovered by flow cytometry, were transferred to a slide, air dried, fixed in acetone, washed in sterile PBS, and incubated with a FITC-conjugated IgG2b mAb specific for murine Mac-1 (clone M1/70; PharMingen) a FITC-conjugated mAb to CD18 (C71/16) or a FITC-conjugated IgG isotype control. BMCMCs were stained with both anti-c-kit PE and anti-Mac-1-FITC mAbs or a directly conjugated IgG isotype control as described (9), and analyzed on a FACSCalibur (Becton Dickinson, San Jose, CA).
Histological quantification of MCs
PMCs were stained and counted with Kimura stain (19). The numbers of MCs in tissue was counted by light microscopy (x400) of Alcian blue-stained sections of Carnoy’s fixed, paraffin-embedded tissues (4). The data were expressed as the number of MCs per mm2 of tissue, except in the jejunal mucosa, where it was MC per villus crypt unit. The histological analysis was performed by an observer who was blinded to the origin of the tissue sections.
Induction of CLP
Mice were subjected to CLP, as has been previously described
(7). Briefly, 20 wild-type and 20 Mac-1-/-, 8- to
12-wk-old male mice were anesthetized and subjected to ligation of
50% of the distal end of the cecum followed by a single puncture
with a 0.7-mm needle. After the procedure, animals were observed for
mortality over a period of 14 days. Lavage fluid was harvested from
select mice before and 3 h following CLP: The total number of
cells present was assessed on a hematocytometer and a differential
count on cytospinned samples was performed as previously described
(13). Cell associated and spontaneously released histamine in
peritoneal fluid was measured by enzyme-immunoassay (Immunotech,
Westbrook, ME), and TNF-
levels in peritoneal fluid were detected by
ELISA (R&D Systems, Minneapolis, MN) using manufacturers protocols.
Assessment of CFU of bacteria
Five wild-type and five Mac-1-/- mice were subjected to CLP and, at 1 or 3 h after CLP, peritoneal lavage fluid was collected and pooled for each genotype. CFU of bacteria were determined by overnight culture of serial dilutions of peritoneal lavage fluid as previously described (20).
Statistical analysis
Data are presented as average ± SEM. Statistical significance was assessed by the Mantel-Cox Logrank test for the survival rate in the CLP experiment, and by unpaired Student’s t test for the remainder of the experiments.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
MCs represent only 1–3% of the cells recovered from the
peritoneal lavage of mice, while the remainder of the cells are
predominantly Mac-1 positive macrophages that aggregate with MCs upon
addition of Ab (data not shown). Therefore, a pure population of PMCs
was first obtained from wild-type and Mac-1-/- mice by
FACs sort of c-kit-positive cells before subjecting samples
to immunofluorescence staining with Mac-1 Ab and IgG isotype control.
Among mature hematopoietic cells, c-kit is only
significantly expressed on MCs (21). In the wild-type MC population,
30–40% of the c-kit-positive MCs were positive for
Mac-1, whereas all c-kit-positive cells from
Mac-1-/- mice incubated with the anti-Mac-1 Ab
revealed staining that was similar to that observed in the IgG control.
c-kit-positive peritoneal MCs from wild-type and
Mac-1-deficient mice were also positive for CD18. The percentages of
wild-type or Mac-1-deficient MCs that were positive for CD18 was
similar to that seen in wild-type MC populations stained with Ab to
Mac-1 alone (Fig. 1
). Similarly, Mac-1
was expressed at a frequency of 30% by wild-type PMCs purified by
density centrifugation (data not shown). Mac-1 expression was also
determined in MCs that were differentiated in vitro by maintaining bone
marrow cells derived from wild-type and Mac-1-/- mice in
medium containing rIL-3. IL-3 differentiates MC progenitors into
immature MCs that are c-kit positive (>95%) (1, 2, 3); these
cells are referred to herein as BMCMCs. c-kit-positive
wild-type BMCMCs had weak, if any, surface Mac-1 expression as assessed
by FACs analysis, and c-kit-positive BMCMCs from
Mac-1-/- mice were completely negative (Fig. 1B). However, Mac-1 expression could be up-regulated on
wild-type BMCMCs upon their incubation with LPS from E. coli
for 24 h (Fig. 1B).
|
As part of an effort to assess the physiological relevance of
Mac-1 on MCs, we quantified the numbers of MCs resident in several
tissues harvested from wild-type and Mac-1-/- mice.
Significant reductions in the numbers of MCs were observed in the
peritoneal cavity and in the peritoneal wall of Mac-1-/-
mice (Table I), whereas the total number
of cells in the peritoneal cavity of wild-type and
Mac-1-/- mice as well as the number of peritoneal
macrophages were similar in mice of both genotypes (data not shown)
(13). All of the PMCs in Mac-1-/- and wild-type mice
stained positive for Alcian blue and safranin, as would be expected for
mature serosal-type MCs (data not shown). The number of MCs in the
dorsal skin dermis, but not in the ear skin dermis of
Mac-1-/- animals, was also reduced compared with their
wild-type littermates. In the jejunal and cecal mucosa and spleen,
Mac-1-/- and wild-type mice had comparable numbers of MCs
(Table I).
|
The role of Mac-1 in MC-dependent innate immunity was examined by
subjecting Mac-1-/- and wild-type mice to CLP, an acute
septic peritonitis model in which enteric bacteria are released into
the peritoneum. This model is both MC (7) and complement (20)
dependent. Mac-1-/- mice subjected to CLP had
significantly increased mortality (50%) compared with wild-type mice
(10%, p = 0.009) by 48 h after CLP, a difference
which persisted throughout the 14-day period of observation (Fig. 2A). This increased
susceptibility of Mac-1-/- mice to sepsis is probably due
to a defect in bacterial clearance: The number of CFU in peritoneal
lavage fluid of Mac-1-/- mice was nearly threefold higher
than in wild-type mice after 1 h (wild-type: 0.5 x
104 CFU; Mac-1-/-: 1.4 x
104 CFU), and was still 1.5 fold higher at 3 h after
CLP (wild-type: 90 x 104 CFU; Mac-1-/-:
142 x 104 CFU).
|
B). The actual
difference may even be underestimated since we have previously shown
that neutrophil apoptosis is delayed in Mac-1-/-
mice, thus leading to enhanced neutrophil accumulation in the
peritoneum of Mac-1-/- mice during chemically induced
peritonitis (13). Histamine was diminished by 84% in
Mac-1-/- mice 3 h after CLP (Fig. 2C). A
decrease in total histamine content at 3 h following CLP vs
baseline in both genotypes is probably the result of degranulation of
MCs and subsequent metabolism of this MC marker. Preliminary
experiments have revealed no difference in TNF- in wild-type vs
Mac-1-/- mice (data not shown). |
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In the present study, Mac-1 was shown on MCs harvested from the
peritoneal cavity of mice, which to our knowledge is the first report
of Mac-1 on non-neoplastic in vivo-derived MCs. However, only
30–40% of the total population of PMCs were reproducibly Mac-1
positive. This suggests that surface expression of Mac-1 in PMCs may be
subject to regulation by microenvironmental signals. Indeed, MCs can
express substantial heterogeneity with respect to multiple
characteristics, including their content of MC proteases and other
mediators (1, 2, 3, 6) as well as their proliferative potential. For
example, only 25% of morphologically mature PMCs proliferate in
methycellulose culture in vitro (22). We show that BMCMCs can be
induced to express Mac-1 upon stimulation with endotoxin. In mice,
changes in the phenotypic characteristics of MC populations, in
response to alterations in the microenvironment, may allow the MCs to
respond appropriately to local changes associated with diseases or
immunologic responses (1, 2, 3).
Mac-1-/- mice had significant reductions in the numbers of MCs resident in certain anatomical sites. The mechanisms that influence the establishment of resident MC populations may differ for different organs at least in adult mice (23, 24) and remain poorly understood. How Mac-1 affects the establishment of resident MC populations is not yet clear, but our study is the first demonstration that an adhesion receptor can significantly influence this process. Populations of resident MCs can be maintained by migration of MC progenitors, as well as by the proliferation and survival of differentiated MCs (3, 4). It is possible that Mac-1 plays a role in one or more of these processes. A committed MC precursor cell (the "pro-mastocyte") has been identified in the circulation of fetal mice (5), but the mechanisms that regulate the migration and distribution of immature and mature MCs are largely unclarified. Given that Mac-1 on neutrophils and monocytes plays a prominent role in leukocyte trafficking through interaction of these leukocytes with the endothelium (12), it is possible that Mac-1 may play a similar role in recruitment of MC progenitors by facilitating their interaction with endothelial cells. Our finding that Mac-1 is important in establishing resident MCs in some tissues, such as the peritoneum and skin, but not in others further highlights the heterogeneity in the mechanisms which can regulate the baseline levels of MCs in different organs as has been suggested by previous studies (23, 24). It is possible that in tissues where Mac-1-/- mice had no reduction of MCs that Mac-1 is not expressed on these MCs and/or their progenitors, and therefore is not important in the biology of these MC populations, or that these cells do express Mac-1, but that Mac-1 is not critical in establishing or maintaining baseline populations of MCs at these sites. A parallel situation occurs in the biology of neutrophils, in that Mac-1 is expressed in all neutrophils, yet is not important in the recruitment of neutrophils in all inflammatory conditions (25).
The relevance of Mac-1 on MCs in innate immunity was investigated using a MC-dependent model of bacterial infection in the peritoneum (CLP), a site where Mac-1 is expressed on PMCs and the number of PMCs in Mac-1-/- mice is significantly less than in wild-type mice. Following CLP, the Mac-1-/- mice exhibited significant mortality compared with wild-type mice, which was associated with an increased bacterial burden. The defect in bacterial clearance in Mac-1-/- mice may be due to one or more of the many consequences of the animals’ Mac-1 deficiency. For example, the defect may be related to the observed reduction in neutrophil accumulation into the peritoneum, perhaps reflecting decreased MC-derived mediators in the peritoneum of Mac-1-/- mice. The defect may also reflect abnormalities in other processes which have been shown to be Mac-1 dependent. These include the inability of Mac-1-/- neutrophils to adhere normally to the endothelium, and/or to bind complement and phagocytose bacteria (26).
Our studies provide evidence that an adhesion molecule can regulate MC development and/or survival in vivo, and can importantly influence the expression of a MC-dependent innate immune response in vivo.
|
Footnotes |
|---|
2 These authors contributed equally to this work.
3 Address correspondence and reprint requests to Tanya N. Mayadas, Vascular Research Division, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, 221 Longwood Ave., Rm 404, Boston, MA 02115. E-mail address:
4 Abbreviations used in this paper: MCs, mast cells; PMCs, peritoneal mast cells; BMCMCs, bone marrow-derived cultured mast cells; CLP, cecal ligation and puncture.
Received for publication July 20, 1998. Accepted for publication October 19, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
. Nature 381:77.[Medline]
receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 186:1853.This article has been cited by other articles:
|
|
 |
|
  K. D. McCall-Culbreath, Z. Li, and M. M. Zutter Crosstalk between the {alpha}2{beta}1 integrin and c-met/HGF-R regulates innate immunity Blood, April 1, 2008; 111(7): 3562 - 3570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Siebenhaar, W. Syska, K. Weller, M. Magerl, T. Zuberbier, M. Metz, and M. Maurer Control of Pseudomonas aeruginosa Skin Infections in Mice Is Mast Cell-Dependent Am. J. Pathol., June 1, 2007; 170(6): 1910 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Schirmer, S.-C. Song, J. P. Baliff, S. O. Harbers, R. A. Clynes, A. Krop-Watorek, G. R. Halverson, M. Czerwinski, and S. L. Spitalnik Mouse models of IgG- and IgM-mediated hemolysis Blood, April 1, 2007; 109(7): 3099 - 3107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yu, J. Luo, W. Yang, Y. Wang, M. Mizuki, Y. Kanakura, P. Besmer, B. G. Neel, and H. Gu The Scaffolding Adapter Gab2, via Shp-2, Regulates Kit-evoked Mast Cell Proliferation by Activating the Rac/JNK Pathway J. Biol. Chem., September 29, 2006; 281(39): 28615 - 28626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Renckens, J. J. T. H. Roelofs, S. Florquin, A. F. de Vos, H. R. Lijnen, C. van't Veer, and T. van der Poll Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis J. Immunol., March 15, 2006; 176(6): 3735 - 3741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Cailhier, D. A. Sawatzky, T. Kipari, K. Houlberg, D. Walbaum, S. Watson, R. A. Lang, S. Clay, D. Kluth, J. Savill, et al. Resident Pleural Macrophages Are Key Orchestrators of Neutrophil Recruitment in Pleural Inflammation Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 540 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Oki, J. Kitaura, K. Eto, Y. Lu, M. Maeda-Yamamoto, N. Inagaki, H. Nagai, Y. Yamanishi, H. Nakajina, H. Kumagai, et al. Integrin {alpha}IIb{beta}3 Induces the Adhesion and Activation of Mast Cells through Interaction with Fibrinogen J. Immunol., January 1, 2006; 176(1): 52 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Y. Tanga, N. Nutile-McMenemy, and J. A. DeLeo The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy PNAS, April 19, 2005; 102(16): 5856 - 5861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Frossi, M. De Carli, and C. Pucillo The mast cell: an antenna of the microenvironment that directs the immune response J. Leukoc. Biol., April 1, 2004; 75(4): 579 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Edelson, Z. Li, L. K. Pappan, and M. M. Zutter Mast cell-mediated inflammatory responses require the {alpha}2{beta}1 integrin Blood, March 15, 2004; 103(6): 2214 - 2220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yanaba, Y. Kaburagi, K. Takehara, D. A. Steeber, T. F. Tedder, and S. Sato Relative Contributions of Selectins and Intercellular Adhesion Molecule-1 to Tissue Injury Induced by Immune Complex Deposition Am. J. Pathol., May 1, 2003; 162(5): 1463 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shimada, M. Hasegawa, Y. Kaburagi, Y. Hamaguchi, K. Komura, E. Saito, K. Takehara, D. A. Steeber, T. F. Tedder, and S. Sato L-Selectin or ICAM-1 Deficiency Reduces an Immediate-Type Hypersensitivity Response by Preventing Mast Cell Recruitment in Repeated Elicitation of Contact Hypersensitivity J. Immunol., April 15, 2003; 170(8): 4325 - 4334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Graham, L. M. Smoot, C. A. L. Migliaccio, K. Virtaneva, D. E. Sturdevant, S. F. Porcella, M. J. Federle, G. J. Adams, J. R. Scott, and J. M. Musser Virulence control in group A Streptococcus by a two-component gene regulatory system: Global expression profiling and in vivo infection modeling PNAS, October 15, 2002; 99(21): 13855 - 13860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Boyce, E. A. Mellor, B. Perkins, Y.-C. Lim, and F. W. Luscinskas Human mast cell progenitors use alpha 4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions Blood, April 15, 2002; 99(8): 2890 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kaburagi, M. Hasegawa, T. Nagaoka, Y. Shimada, Y. Hamaguchi, K. Komura, E. Saito, K. Yanaba, K. Takehara, T. Kadono, et al. The Cutaneous Reverse Arthus Reaction Requires Intercellular Adhesion Molecule 1 and L-Selectin Expression J. Immunol., March 15, 2002; 168(6): 2970 - 2978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kanwar, C. W. Smith, F. R. Shardonofsky, and A. R. Burns The Role of Mac-1 (CD11b/CD18) in Antigen-Induced Airway Eosinophilia in Mice Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 170 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bouvard, C. Brakebusch, E. Gustafsson, A. Aszodi, T. Bengtsson, A. Berna, and R. Fassler Functional Consequences of Integrin Gene Mutations in Mice Circ. Res., July 30, 2001; 89(3): 211 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Forsyth, D. A. Solovjov, T. P. Ugarova, and E. F. Plow Integrin {alpha}M{beta}2-mediated Cell Migration to Fibrinogen and Its Recognition Peptides J. Exp. Med., May 14, 2001; 193(10): 1123 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Gommerman, D. Y. Oh, X. Zhou, T. F. Tedder, M. Maurer, S. J. Galli, and M. C. Carroll A Role for CD21/CD35 and CD19 in Responses to Acute Septic Peritonitis: A Potential Mechanism for Mast Cell Activation J. Immunol., December 15, 2000; 165(12): 6915 - 6921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-M. Ding, J. E. Babensee, S. I. Simon, H. Lu, J. L. Perrard, D. C. Bullard, X. Y. Dai, S. K. Bromley, M. L. Dustin, M. L. Entman, et al. Relative Contribution of LFA-1 and Mac-1 to Neutrophil Adhesion and Migration J. Immunol., November 1, 1999; 163(9): 5029 - 5038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Harris, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman The Leukocyte Integrins J. Biol. Chem., July 28, 2000; 275(31): 23409 - 23412. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
